Disease stage-dependent expression of ADC-related biomarkers in urothelial carcinoma
Steffen Rausch, Alicia Bombyk, Lena Müller, Jörg Hennenlotter, Moritz Maas, Simon Walz, Igor Tsaur, Veronika Bahlinger, Viktoria Stühler · 2026
Read Disease stage-dependent expression of ADC-related biomarkers in urothelial carcinoma by Steffen Rausch, Alicia Bombyk, Lena Müller, Jörg Hennenlotter, Moritz Maas, Simon Walz, Igor Tsaur, Veronika Bahlinger, Viktoria Stühler (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13561723.txt.
Description
Steffen Rausch and co-authors wrote a study from 2026 on drug targets in bladder cancer. New drugs for this cancer latch onto marks on the tumor cell, so doctors need to know which marks a given tumor bears. The team asked whether those marks change as the disease moves from its first site to nearby nodes. They tested four marks on tissue from healthy lining, first tumors, and spread found in lymph nodes.
The four marks did not rise and fall as one. One mark was stronger in spread tissue than in first tumors and was linked to later stage disease. One was weaker in tumors than in healthy lining. One stayed low but rose a bit in tumors and spread. The team says each patient should be tested on their own tissue, and that samples of the spread may guide drug choice best.
Catalog record
| CREATOR | Steffen Rausch, Alicia Bombyk, Lena Müller, Jörg Hennenlotter, Moritz Maas, Simon Walz, Igor Tsaur, Veronika Bahlinger, Viktoria Stühler |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |